Table 1 Characteristics of included patients
Total number | 50 |
|---|---|
Age (mean ± SD years) | 31.2 ± 6.6 |
 ≤ 18 (n, %) | 0 |
 18–39 (n, %) | 42 (84%) |
 40–49 (n, %) | 7 (14%) |
 ≥ 50 (n, %) | 1 (2%) |
BCG vaccination at birth (n, %) | 50 (100%) |
Type of disease | |
 Ankylosing spondylitis | 33 (66%) |
 Rheumatoid arthritis | 17 (34%) |
Biologic treatment | |
 Infliximab (n, %) | 50 (100%) |
 Each dose (mg) | 200 |
Other treatments | |
 Indomethacin (n, %) | 13 (26%) |
 Daily dose (mg) | 150 |
 Naproxen (n, %) | 4 (8%) |
 Daily dose (mg) | 1500 |
 Diclofenac (n, %) | 16 (32%) |
 Daily dose (mg) | 200 |
 Hydroxychloroquine (n, %) | 17 (34%) |
 Daily dose mean ± SD dose (mg) | 270.5 ± 98.5 |
 Methotrexate (n, %) | 17 (34%) |
 Weekly dose mean ± SD dose (mg) | 13.8 ± 3.3 |
 Prednisolone | |
  Daily dose mean ± SD (mg) |   5.29 ± 1.21 |
  ≤ 2.5 mg (n, %) | 1 (2%) |
  = 5 mg (n, %) | 13 (26%) |
  ≥ 7.5 mg (n, %) | 3 (6%) |
  No prednisolone (n, %) | 33 (66%) |